ANGELA SCOTT: Open Payments
NPI 1578870853 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,592 in 164 payments from 33 companies in 2025. Trend: 2023 $2,245 · 2024 $3,896 · 2025 $3,592
Food & beverage: $3,592
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $417 |
| E.R. Squibb & Sons, L.L.C. | 20 | $371 |
| Merck Sharp & Dohme LLC | 10 | $237 |
| Exelixis Inc. | 6 | $214 |
| AstraZeneca Pharmaceuticals LP | 11 | $208 |
| Lilly USA, LLC | 8 | $202 |
| PFIZER INC. | 9 | $198 |
| Janssen Biotech, Inc. | 9 | $188 |
| GENZYME CORPORATION | 7 | $185 |
| ABBVIE INC. | 8 | $177 |
Products named: KEYTRUDA, CABOMETYX, OPDIVO, ENHERTU, KISQALI, VERZENIO, SCEMBLIX, OPDUALAG.
Industry payments across TN — which companies pay providers there.
